IAPRD 2025
May 7 - 10, 2025 | New York City, NY
The agents listed below are currently under investigation. Their safety and efficacy have not been established.
Poster
First-in-Human Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of ARV-102, a PROTAC LRRK2 Degrader, in Healthy VolunteersL Smits et al.